T32 Post-Doc Katherine Collins is first author of a new publication on personalized lifestyle interventions
Pearls from 2/22/2022 LEADS
The February 22, 2022, session of Duke Medicine LEADS featured Jonathan Bae, MD presenting on "Change Management 101."
Pearls
- Crucial ingredients include clear vision, stakeholder engagement, communication, and leadership.
- Be prepared to, and embrace, failure early and often.
- Culture change is hard and takes a long time.
CAGPM’s Black History Month Spotlight on Julia Walker
Haga authors "The Book of Genes and Genomes"
Kessler honored with inagural AMSUS Communications Award
Congratulations to Duke GIM Professor of Medicine, Dr. Chad Kessler, who received the inaugural national communication award for his creation of the “COVID in 20” program at the (virtual) AMSUS annual meeting on Febryary 10.
Recap: Duke at SGIM Southern
On Feb 9th and 10th, the Society of General Internal Medicine (SGIM) Southern had their second virtual meeting
Bass Connections team publishes study on mobile health interventions in pediatric and young adult populations
New Residency Rotation Builds Diversity, Community Bonds
By Liz Switzer
A new rotation for Internal Medicine residents at the City of Medicine Academy (CMA) in Durham encourages high school students—particularly those from historically excluded groups—to consider careers in medicine and health while giving Duke internal medicine residents a fresh opportunity to engage in greater diversity initiatives while gaining a deeper understanding of the local community.
Internal Medicine Chief Residents Announced for 2023-2024
Kathleen Cooney, MD, MACP, chair of the department, Aimee Zaas, MD, MHS, program director of the Duke Internal Medicine Residency Program, and David Simel, MD, vice chair for Veterans Affairs, have announced the Chief Residents for the 2023-2024 academic year.
A COVID-19 Collaborative: Wahid, Researchers Break Treatment Ground
By Liz Switzer
Internal medicine hospitalist Lana Wahid, MD arrived at Duke Medical Center in April 2020 with a simple goal: becoming involved in clinical research. By December 2020, she had been named Duke site Principal Investigator of the National Institutes of Health (NIH)-funded ACTIV-4a platform trial to evaluate anticoagulation in hospitalized COVID-19 patients and quickly established the Duke Health System as one of the highest enrolling trial sites in this international collaboration.